Journal Zdravotnictví a medicína

Potential of migrastatic therapy

The novel anticancer therapy developed by the research team from international centre Biocev in Prague could prevent cancer cells from forming metastases. The migrastatic agents could thus become a fifth pillar in the treatment of malignancies. More details were presented by the head of the research team, associate professor Jan Brábek, PhD.
 
Journal Zdravotnicví a medicína, 2019/10; 29. 10. 2019; author: MUDr. Andrea Skálová


..for the entire text, see here.